IDRx

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today’s precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Pharmaceutical industry

Location

B2X

CEO

Number of Employees (Ranges)

11 – 50

Email Address

Investors

Blackstone Group

RA Capital Management

Commodore Capital

Total Funding Amount (USD)

120,000,000

Latest Funding Round Date

August 7, 2024

CFO

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

120,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like IDRx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.